Here are six things to know:
1. The market is expected to hit $818 million by 2022.
2. Factors spurring market growth include the growing prevalence of ophthalmic disease, chronic disease and ear, nose and throat diseases.
3. The equipment’s high price may hinder market growth.
4. Last year, the ophthalmology segment held a 25 percent market revenue share. However, the ENT segment is expected to have the fastest growing compound annual growth rate.
5. In 2015, outpatient facilities contributed to 75 percent of the market’s revenue.
6. Through 2022, the Asia-Pacific region is expected to increase at a 10.7 percent CAGR.
More articles on healthcare:
Remaining independent in a consolidating industry — Key thoughts from an Omaha-based ASC administrator
The war on monopolies — courts siding with FTC over hospital mergers: 6 things to know
New England Research & Management buys 4.8k AmSurg shares — 5 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.